-
Notifications
You must be signed in to change notification settings - Fork 1
FL_genes
Gene | Summary | First FL study | Other entities | QC result |
---|---|---|---|---|
ACTB | Tier 1 GE[@drevalGeneticSubdivisionsFollicular2023], aSHM | Dreval et al | [@lohrDiscoveryPrioritizationSomatic2012a; @wienandGenomicAnalysesFlowsorted2019b] | |
ARID1A | Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@barisicARID1AOrchestratesSWI2024], aSHM | Krysiak et al | [@loveGeneticLandscapeMutations2012; @rossiCodingGenomeSplenic2012c; @wienandGenomicAnalysesFlowsorted2019b; @zhangGeneticHeterogeneityDiffuse2013] | |
ATP6AP1 | Tier 1 GE[@okosunRecurrentMTORC1activatingRRAGC2016a] | Okosun et al | ||
ATP6V1B2 | Tier 1 GE[@okosunRecurrentMTORC1activatingRRAGC2016a] | Okosun et al | ||
B2M | Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@challa-malladiCombinedGeneticInactivationa], aSHM | Morin et al | [@pararajalingamCodingNoncodingDrivers2020; @reichelFlowSortingExome2015a] | |
BCL10 | Tier 1 GE[@russler-germainMutationsAssociatedProgression2023b], FE[@xiaBCL10MutationsDefine2022], aSHM | Russler-germain et al | [@morinFrequentMutationHistonemodifying2011; @spinaGeneticsNodalMarginal2016b] | |
BCL2 | Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@balSuperenhancerHypermutationAlters2022], aSHM | Morin et al | [@burkhardtClinicalRelevanceMolecular2022b; @sarkozyMutationalLandscapeGray2021a; @tanakaFrequentIncidenceSomatic1992] | |
BCL6 | Tier 1 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@balSuperenhancerHypermutationAlters2022], aSHM | Dreval et al | [@loveGeneticLandscapeMutations2012; @morinFrequentMutationHistonemodifying2011] | |
BCL7A | Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@balinas-gaviraFrequentMutationsAminoterminal2020b], aSHM | Krysiak et al | [@grandeGenomewideDiscoverySomatic2019; @morinFrequentMutationHistonemodifying2011; @reichelFlowSortingExome2015a] | |
BTK | Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM | Krysiak et al | [@albuquerqueEnhancingKnowledgeDiscovery2017a] | |
CARD11 | Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@lenzOncogenicCARD11Mutations2008], CE[@zhaoExpressionPrognosticValue2016], aSHM | Morin et al | [@lenzOncogenicCARD11Mutations2008; @wuGeneticHeterogeneityPrimary2016; @yanBCRTLRSignaling2012a] | |
CCND3 | Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@schmitzBurkittLymphomaPathogenesis2012], aSHM | Morin et al | [@deschGenotypingCirculatingTumor2020; @jalladesExomeSequencingIdentifies2017; @richterRecurrentMutationID32012a] | |
CD83 | Tier 1 GE[@russler-germainMutationsAssociatedProgression2023b], aSHM | Russler-germain et al | [@dunsCharacterizationDLBCLPMBL2021b; @morinMutationalStructuralAnalysis2013; @paneaWholeGenomeLandscape2019] | |
CREBBP | Tier 1 GE[@pasqualucciInactivatingMutationsAcetyltransferase2011a], FE[@pasqualucciInactivatingMutationsAcetyltransferase2011a], aSHM | Pasqualucci et al | [@dunsCharacterizationDLBCLPMBL2021b; @loveGeneticLandscapeMutations2012; @parryWholeExomeSequencing2013] | |
CTSS | Tier 1 GE[@barariaCathepsinAlterationsInduce2020c] | Bararia et al | ||
EBF1 | Tier 1 GE, aSHM | [@bohleRoleEarlyBcell2013; @reichelFlowSortingExome2015a; @thomasGeneticSubgroupsInform2023] | ||
EEF1A1 | Tier 1 GE[@hubschmannMutationalMechanismsShaping2021b], CE[@gongExpressionClinicalValue2021], aSHM | Hubschmann et al | [@reichelFlowSortingExome2015a] | |
EP300 | Tier 1 GE[@pasqualucciInactivatingMutationsAcetyltransferase2011a], FE[@pasqualucciInactivatingMutationsAcetyltransferase2011a], aSHM | Pasqualucci et al | [@rossiCodingGenomeSplenic2012c] | |
EZH2 | Tier 1 GE[@morinSomaticMutationsAltering2010a], FE[@yapSomaticMutationsEZH22011b], aSHM | Morin et al | [@loveGeneticLandscapeMutations2012; @mottokIntegrativeGenomicAnalysis2019b] | |
FAS | Tier 1 GE, FE[@seebergerLossFasCD952001], aSHM | [@schollMutationsRegionFAS2007; @spinaGeneticsNodalMarginal2016b] | ||
FOXO1 | Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@trinhAnalysisFOXO1Mutations], CE[@trinhAnalysisFOXO1Mutations], aSHM | Morin et al | [@dunsCharacterizationDLBCLPMBL2021b; @schmitzBurkittLymphomaPathogenesis2012] | |
GNA13 | Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@muppidiLossSignalingGa132014b], aSHM | Morin et al | [@loveGeneticLandscapeMutations2012; @reichelFlowSortingExome2015a] | |
GNAI2 | Tier 1 GE, aSHM | [@grandeGenomewideDiscoverySomatic2019; @morinMutationalStructuralAnalysis2013] | ||
HIST1H1B | Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM | Krysiak et al | [@chapuyMolecularSubtypesDiffuse2018b; @sarkozyMutationalLandscapeGray2021a] | |
HIST1H1C | Tier 1 GE[@morinFrequentMutationHistonemodifying2011], aSHM | Morin et al | [@paneaWholeGenomeLandscape2019] | |
HIST1H1D | Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM | Krysiak et al | [@jalladesExomeSequencingIdentifies2017; @morinMutationalStructuralAnalysis2013] | |
HIST1H1E | Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM | Krysiak et al | [@grandeGenomewideDiscoverySomatic2019; @lohrDiscoveryPrioritizationSomatic2012a; @reichelFlowSortingExome2015a] | |
HIST1H2AC | Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM | Krysiak et al | [@morinMutationalStructuralAnalysis2013] | |
HIST1H2AG | Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM | Krysiak et al | [@morinMutationalStructuralAnalysis2013; @paneaWholeGenomeLandscape2019; @rossiCodingGenomeSplenic2012c] | |
HIST1H2AM | Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM | Krysiak et al | [@chapuyMolecularSubtypesDiffuse2018b; @paneaWholeGenomeLandscape2019] | |
HIST1H2BC | Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM | Krysiak et al | [@lohrDiscoveryPrioritizationSomatic2012a; @mottokIntegrativeGenomicAnalysis2019b] | |
HIST1H2BG | Tier 1 GE[@krysiakRecurrentSomaticMutations2017b] | Krysiak et al | ||
HVCN1 | Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM | Krysiak et al | [@chapuyMolecularSubtypesDiffuse2018b] | |
IRF4 | Tier 1 GE[@drevalGeneticSubdivisionsFollicular2023], aSHM | Dreval et al | [@morinFrequentMutationHistonemodifying2011; @mottokIntegrativeGenomicAnalysis2019b] | |
IRF8 | Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@qiuIRF8mutantCellLymphoma2024], aSHM | Morin et al | [@mottokIntegrativeGenomicAnalysis2019b; @paneaWholeGenomeLandscape2019] | |
KLHL6 | Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@merirantaDisruptionKLHL6Fuels2024], aSHM | Morin et al | [@ganapathiGeneticLandscapeDural2016] | |
KMT2D | Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@liLossCREBBPKMT2D2024], CE[@rushtonGeneticEvolutionaryPatterns2020], aSHM | Morin et al | [@beaLandscapeSomaticMutations2013; @deschGenotypingCirculatingTumor2020; @grandeGenomewideDiscoverySomatic2019; @rossiCodingGenomeSplenic2012c] | |
MAP2K1 | Tier 1 GE[@louissaintPediatrictypeNodalFollicular2016a], aSHM | Louissaint et al | [@shinBRAFV600EMAP2K12015] | |
MEF2B | Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@yingMEF2BMutationsLead], aSHM | Morin et al | [@beaLandscapeSomaticMutations2013] | |
MYC | Tier 1 GE, FE[@giallongoIdentificationCmycOncogene1983], CE[@christieCMYCTranslocation142008], aSHM | [@dunsCharacterizationDLBCLPMBL2021b; @jalladesExomeSequencingIdentifies2017; @johnstonCmycHypermutationBurkitt1992; @pasqualucciHypermutationMultipleProtooncogenes2001a] | ||
PIM1 | Tier 1 GE[@drevalGeneticSubdivisionsFollicular2023], CE[@guoSGK1MutationStatus2022b], aSHM | Dreval et al | [@burkhardtClinicalRelevanceMolecular2022b; @dunsCharacterizationDLBCLPMBL2021b; @pasqualucciHypermutationMultipleProtooncogenes2001a] | |
POU2AF1 | Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM | Krysiak et al | [@chapuyMolecularSubtypesDiffuse2018b] | |
POU2F2 | Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@hodsonRegulationNormalBcell2016a], aSHM | Krysiak et al | [@lohrDiscoveryPrioritizationSomatic2012a] | |
RRAGC | Tier 1 GE[@okosunRecurrentMTORC1activatingRRAGC2016a], FE[@ortega-molinaOncogenicRagGTPase2019b], aSHM | Okosun et al | ||
SGK1 | Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@hartmannHighlyRecurrentMutations2016b], CE[@guoSGK1MutationStatus2022b], aSHM | Morin et al | [@dunsCharacterizationDLBCLPMBL2021b] | |
SMARCA4 | Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@dengSMARCA4HaploinsufficientCell2024], aSHM | Krysiak et al | [@nadeuGenomicEpigenomicInsights2020b; @reddyGeneticFunctionalDrivers2017; @richterRecurrentMutationID32012a] | |
SOCS1 | Tier 1 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@melznerBiallelicMutationSOCS12005a], aSHM | Dreval et al | [@morinFrequentMutationHistonemodifying2011; @wenigerMutationsTumorSuppressor2006a] | |
STAT6 | Tier 1 GE[@yildizActivatingSTAT6Mutations2015c], FE[@yildizActivatingSTAT6Mutations2015c], aSHM | Yildiz et al | [@ritzRecurrentMutationsSTAT62009a] | |
TBL1XR1 | Tier 1 GE, FE[@venturuttiTBL1XR1MutationsDrive2020b], aSHM | [@lohrDiscoveryPrioritizationSomatic2012a; @rossiCodingGenomeSplenic2012c] | ||
TMSB4X | Tier 1 GE, aSHM | [@zhangGeneticHeterogeneityDiffuse2013] | ||
TNFAIP3 | Tier 1 GE, FE[@compagnoMutationsMultipleGenes2009a], aSHM | [@compagnoMutationsMultipleGenes2009a; @rossiAlterationBIRC3Multiple2011a; @schmitzTNFAIP3A20Tumor2009a] | ||
TNFRSF14 | Tier 1 GE[@cheungAcquiredTNFRSF14Mutations2010a], CE[@guoSGK1MutationStatus2022b], aSHM | Cheung et al | [@morinFrequentMutationHistonemodifying2011; @spinaGeneticsNodalMarginal2016b] | |
TP53 | Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@rowhTp53DeletionLineage2011], aSHM | Morin et al | [@beaLandscapeSomaticMutations2013; @lohrDiscoveryPrioritizationSomatic2012a; @rossiCodingGenomeSplenic2012c; @tiacciPervasiveMutationsJAKSTAT2018b; @wildaInactivationARFMDM2p53Pathway2004] | |
VMA21 | Tier 1 GE[@hubschmannMutationalMechanismsShaping2021b] | Hubschmann et al |
Gene | Summary | First FL study | Other entities | QC result |
---|---|---|---|---|
ABL2 | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] | Russler-germain et al | ||
ACTG1 | Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b], aSHM | Hubschmann et al | [@deschGenotypingCirculatingTumor2020; @spinaGeneticsNodalMarginal2016b] | |
ATP6V1A | Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b] | Hubschmann et al | ||
BIRC6 | Tier 2 GE, aSHM | [@reddyGeneticFunctionalDrivers2017; @sarkozyMutationalLandscapeGray2021a] | ||
BTG1 | Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@mlynarczykBTG1MutationYields2023b], aSHM | Dreval et al | [@burkhardtClinicalRelevanceMolecular2022b; @morinFrequentMutationHistonemodifying2011; @sarkozyMutationalLandscapeGray2021a] | |
BTG2 | Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], CE[@guoMutationBTG2Gene2022b], aSHM | Dreval et al | [@loveGeneticLandscapeMutations2012; @morinFrequentMutationHistonemodifying2011] | |
CD70 | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b], aSHM | Russler-germain et al | [@morinFrequentMutationHistonemodifying2011] | |
CD79B | Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@davisChronicActiveBcellreceptor2010], aSHM | Dreval et al | [@morinFrequentMutationHistonemodifying2011; @paneaWholeGenomeLandscape2019] | |
CDC42BPB | Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b] | Hubschmann et al | [@spinaGeneticsNodalMarginal2016b] | |
CILP | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] | Russler-germain et al | ||
CPNE8 | Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b] | Hubschmann et al | ||
CXCR4 | Tier 2 GE[@krysiakRecurrentSomaticMutations2017b], aSHM | Krysiak et al | [@khodabakhshiRecurrentTargetsAberrant2012; @paneaWholeGenomeLandscape2019] | |
CYP2A6 | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] | Russler-germain et al | ||
DDX3X | Tier 2 GE, FE[@gongSequentialInverseDysregulation2021], CE[@kizhakeyilDDX3XLossAdverse2021], aSHM | [@mottokIntegrativeGenomicAnalysis2019b; @reddyGeneticFunctionalDrivers2017; @schmitzBurkittLymphomaPathogenesis2012] | ||
DHX15 | Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b] | Hubschmann et al | ||
DTX1 | Tier 2 GE, FE[@demirandaExomeSequencingReveals2014], CE[@merirantaDeltex1MutationsPredict2017b], aSHM | [@gomezUltraDeepSequencingReveals2023; @loveGeneticLandscapeMutations2012; @rossiCodingGenomeSplenic2012c; @zhangGeneticHeterogeneityDiffuse2013] | ||
DUSP2 | Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], aSHM | Dreval et al | [@dunsCharacterizationDLBCLPMBL2021b; @lohrDiscoveryPrioritizationSomatic2012a] | |
EGR1 | Tier 2 GE[@krysiakRecurrentSomaticMutations2017b] | Krysiak et al | [@reichelFlowSortingExome2015a; @rossiCodingGenomeSplenic2012c] | |
FZR1 | Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b] | Hubschmann et al | ||
GBP7 | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] | Russler-germain et al | ||
GRM6 | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] | Russler-germain et al | ||
HIST1H2BD | Tier 2 GE[@krysiakRecurrentSomaticMutations2017b] | Krysiak et al | ||
HIST1H2BM | Tier 2 GE[@krysiakRecurrentSomaticMutations2017b] | Krysiak et al | ||
HIST1H3B | Tier 2 GE, aSHM | [@lohrDiscoveryPrioritizationSomatic2012a; @reichelFlowSortingExome2015a] | ||
HIST1H3G | Tier 2 GE[@krysiakRecurrentSomaticMutations2017b] | Krysiak et al | ||
HIST1H3I | Tier 2 GE[@krysiakRecurrentSomaticMutations2017b] | Krysiak et al | [@paneaWholeGenomeLandscape2019] | |
HLA-B | Tier 2 GE, aSHM | [@lohrDiscoveryPrioritizationSomatic2012a; @wienandGenomicAnalysesFlowsorted2019b] | ||
IGLL5 | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b], aSHM | Russler-germain et al | [@chapuyMolecularSubtypesDiffuse2018b; @deschGenotypingCirculatingTumor2020; @paneaWholeGenomeLandscape2019] | |
ITPKB | Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], aSHM | Dreval et al | [@reichelFlowSortingExome2015a; @schmitzGeneticsPathogenesisDiffuse2018a] | |
JUP | Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b] | Hubschmann et al | ||
KIR3DL1 | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] | Russler-germain et al | ||
KLF2 | Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], aSHM | Dreval et al | [@deschGenotypingCirculatingTumor2020; @jalladesExomeSequencingIdentifies2017; @pasqualucciAnalysisCodingGenome2011] | |
LAPTM5 | Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b], aSHM | Hubschmann et al | ||
LTB | Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], aSHM | Dreval et al | [@chapuyMolecularSubtypesDiffuse2018b; @deschGenotypingCirculatingTumor2020] | |
MAGEC1 | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] | Russler-germain et al | ||
MAP7D1 | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] | Russler-germain et al | ||
MEF2C | Tier 2 GE, FE[@jingjingNovelMEF2CMutation2020], aSHM | [@arthurGenomewideDiscoverySomatic2018] | ||
MGEA5 | Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b] | Hubschmann et al | ||
MKI67 | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] | Russler-germain et al | [@schmitzBurkittLymphomaPathogenesis2012] | |
MYCBP2 | Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b] | Hubschmann et al | ||
MYD88 | Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@ngoOncogenicallyActiveMYD882011a], CE[@guoSGK1MutationStatus2022b], aSHM | Dreval et al | [@ngoOncogenicallyActiveMYD882011a; @yanBCRTLRSignaling2012a] | |
NFKBIA | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b], aSHM | Russler-germain et al | [@thomasMutationalAnalysisIkappaBalpha2004; @wienandGenomicAnalysesFlowsorted2019b] | |
OR8H2 | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] | Russler-germain et al | ||
P2RY8 | Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@muppidiLossSignalingGa132014b], aSHM | Dreval et al | [@lohrDiscoveryPrioritizationSomatic2012a; @muppidiLossSignalingGa132014b] | |
PDS5B | Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b], aSHM | Hubschmann et al | [@morinMutationalStructuralAnalysis2013] | |
PPP4C | Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b] | Hubschmann et al | ||
PRKDC | Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b], aSHM | Hubschmann et al | [@schmitzGeneticsPathogenesisDiffuse2018a] | |
PTPRD | Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], aSHM | Dreval et al | [@spinaGeneticsNodalMarginal2016b] | |
PZP | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] | Russler-germain et al | ||
RBM6 | Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b] | Hubschmann et al | ||
S1PR2 | Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@floriHematopoieticOncoproteinFOXP12016], aSHM | Dreval et al | [@morinFrequentMutationHistonemodifying2011; @muppidiLossSignalingGa132014b] | |
SHROOM3 | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] | Russler-germain et al | ||
SRRM2 | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b], aSHM | Russler-germain et al | [@morinMutationalStructuralAnalysis2013] | |
STAB2 | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] | Russler-germain et al | ||
TMEM30A | Tier 2 GE[@morinFrequentMutationHistonemodifying2011], FE[@ennishiTMEM30ALossoffunctionMutations2020b], CE[@ennishiTMEM30ALossoffunctionMutations2020b], aSHM | Morin et al | ||
TPP1 | Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b] | Hubschmann et al | ||
XIRP2 | Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] | Russler-germain et al | ||
ZC3H12A | Tier 2 GE, aSHM | [@chapuyMolecularSubtypesDiffuse2018b] | ||
ZNF608 | Tier 2 GE[@krysiakRecurrentSomaticMutations2017b], aSHM | Krysiak et al | [@morinMutationalStructuralAnalysis2013] |
Gene | Summary | First FL study | Other entities | QC result |
---|
Disclaimer
The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.
In particular, let us know if you feel that an important citation is missing or if a paper has been cited incorrectly.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.